Thomas Hallam SEC EDGAR Filings (CIK 0001850921)

SEC EDGAR filings, ownership reports, and insider transactions for Thomas Hallam.

Business address
C/O Seneca Biopharma, Inc., 20271 Goldenrod Lane, Germantown, MD, 20876
Top holdings (ownership)
PALI
Get insider transactions for this reporting owner
Thomas Hallam has filed 7 SEC EDGAR filings since 29 Apr 2021

Latest Filings

Recent SEC filings for Thomas Hallam including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 18 Aug 2022 16 Aug 2022 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Mar 2022 28 Mar 2022 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Feb 2022 17 Feb 2022 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Feb 2022 18 Nov 2021 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Sep 2021 21 Sep 2021 001-33672
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Apr 2021 27 Apr 2021 001-33672
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 29 Apr 2021 27 Apr 2021 001-33672

About this filer

Thomas Hallam files with the SEC under CIK 0001850921. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages